Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries

11 septembre 2015 mis à jour par: Harry Hemingway, University College, London

Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries: a Cohort Study in Linked Electronic Health Records

Most patients with dementia in the UK use their local hospitals and general (family) practices throughout their illness. Linked electronic health records from primary care, hospital and death certificates records therefore provide useful information about the diagnosis and prognosis of patients who develop dementia.

In this study we will assess the validity of dementia diagnoses in linked primary care, hospital and death records, by examining the timing of important health transitions in patients with recorded dementia, and we will estimate the lifetime risk of recorded dementia in different age and sex groups

Aperçu de l'étude

Statut

Inconnue

Les conditions

Description détaillée

Dementia is a clinical syndrome with insidious onset that is difficult to diagnose in its earliest stages. Presentation to healthcare depends not only upon the rates of disease progression, but also on social support, recognition by clinicians, and patients' and carers' fear of diagnosis. Maintaining complete follow up in cohorts of patient with dementia is difficult, because patients with dementia are frequently lost to follow up.

Most patients with dementia in the UK use their local hospitals and general (family) practices throughout their illness. Linked electronic health records from primary care, hospital and death certificates records should therefore provide useful information about the diagnosis and prognosis of patients who develop dementia with minimal loss to follow-up rates and improved completeness of diagnosis.

Demonstrating that patients with recorded dementia have an earlier onset of typical symptoms, functional impairment and death than patients in the general population would support the veracity of diagnosed dementia recorded in electronic health records and its use as an outcome or exposure in cohort studies and for evaluating policy. Previous studies have found that dementia is poorly recorded in routine clinical practice in comparison to face-to-face studies, although this varies by setting and region. However, ascertainment may be improved by examining linked, longitudinal resources. Comparing the lifetime risk of dementia calculated from linked electronic health records with lifetime risks from other sources will also be a useful information to support the use of linked electronic health records in dementia research.

Electronic health records contain information on important health transitions in patients with dementia: from the earliest stage of the illness (depression, anxiety, memory complaints); the development of cognitive impairment that manifest as loss of capacity or missed appointments; and significant functional impairment, with admission to nursing homes or hospital admission. In this study, we will assess the validity of dementia diagnoses in linked primary care, hospital and death records, by examining the timing of important health transitions in patients with recorded dementia, and estimate the lifetime risk of recorded dementia in different age and sex groups.

Type d'étude

Observationnel

Inscription (Anticipé)

51000

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • London, Royaume-Uni
        • London Farr Institute of Health Informatics

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Patients registered in English general practices contributing with data to the CALIBER research platform from 1997 onward.

La description

Inclusion Criteria:

  • Patients aged 18 years and over
  • Registered with a participating general practice during the study period
  • Minimum one year of records prior to study entry meeting CPRD data quality criteria
  • Followed on or after 1 January 1997

Exclusion Criteria:

  • Patients without recorded gender
  • Less than 1 year of follow-up between study entry and date of administrative censoring

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Dementia
Patients with a recorded diagnosis of dementia in primary or secondary care
This study is based on the retrospective analysis of linked electronic health records.
Non-dementia
Patients without a recorded diagnosis of dementia in primary or secondary care
This study is based on the retrospective analysis of linked electronic health records.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Proportion of patients with dementia diagnosis (any type) in primary care that also are recorded in secondary care
Délai: 10 years
10 years
Factors associated with dementia diagnosis (any type) recording in mortality data only
Délai: 10 years
These will be estimated from multivariable logistic regression models
10 years
Symptoms associated with subsequent diagnosis of dementia
Délai: 10 years
These will be estimated from multivariable logistic regression models
10 years
Lifetime risk of dementia (any type)
Délai: 10 years
10 years
Lifetime risk of mortality associated with dementia (any time)
Délai: 10 years
10 years
Factors associated with dementia diagnosis (any type) recording in secondary care only
Délai: 10 years
These will be estimated from multivariable logistic regression models
10 years
Factors associated with dementia diagnosis (any type) recording in primary care only
Délai: 10 years
These will be estimated from multivariable logistic regression models
10 years
Proportion of patients with dementia diagnosis (any type) in primary care that also are recorded in mortality data
Délai: 10 years
10 years
Proportion of patients with dementia diagnosis (any type) in secondary care that also are recorded in mortality data
Délai: 10 years
10 years

Mesures de résultats secondaires

Mesure des résultats
Délai
Proportion of patients with Alzheimer's disease in primary care that are also diagnosed in secondary care
Délai: 10 years
10 years
Proportion of patients with vascular dementia in primary care that are also diagnosed in secondary care
Délai: 10 years
10 years
Lifetime risk of Alzheimer's disease
Délai: 10 years
10 years
Lifetime risk of vascular dementia
Délai: 10 years
10 years
Lifetime risk of mortality associated with Alzheimer's disease
Délai: 10 years
10 years
Proportion of patients with Alzheimer's disease in primary care that are also diagnosed in mortality data
Délai: 10 years
10 years
Proportion of patients with Alzheimer's disease in secondary care that are also recorded in mortality data
Délai: 10 years
10 years
Proportion of patients with vascular dementia in primary care that are also recorded in secondary care
Délai: 10 years
10 years
Proportion of patients with vascular dementia in secondary care that are also recorded in mortality data
Délai: 10 years
10 years

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 septembre 2015

Achèvement primaire (Anticipé)

1 octobre 2015

Achèvement de l'étude (Anticipé)

1 décembre 2015

Dates d'inscription aux études

Première soumission

3 septembre 2015

Première soumission répondant aux critères de contrôle qualité

11 septembre 2015

Première publication (Estimation)

15 septembre 2015

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

15 septembre 2015

Dernière mise à jour soumise répondant aux critères de contrôle qualité

11 septembre 2015

Dernière vérification

1 septembre 2015

Plus d'information

Termes liés à cette étude

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

3
S'abonner